Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 15/3/2021
SIETES contiene 93212 citas

 
 
 1 a 20 de 1784 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Castells MC, Phillips EJ. Maintaining safety with SARS-CoV-2 vaccines. N Engl J Med 2021;384:18 de febrero. [Ref.ID 103836]
2. Cita con resumen
Parsons L. Moderna scores FDA panel backing for mRNA-based COVID-19 vaccine. PMLiVE 2020:18 de diciembre. [Ref.ID 103823]
4. Cita con resumen
Thomas R. New Pfizer results: coronavirus vaccine is safe and 95% effective. N Y Times (Print) 2020:1. [Ref.ID 103781]
5.Enlace a cita original Cita con resumen
Gerhard T, Stroup TS, Correll CU, Setoguchi S, Strom BL, Huang C, Tan Z, Crystal S, Olfson M. Mortality risk of antipsychotic augmentation for adult depression. PLoS One 2020;5:30 de septiembre. [Ref.ID 103735]
6.Enlace a cita original Cita con resumen
The RECOVERY Collaborative Group. Effect of hydroxychloroquine in hospitalized patients with covid-19. N Engl J Med 2020;383:8 de octubre. [Ref.ID 103732]
7. Cita con resumen
Sharrets J, Galescu O, Gomatam S, Andraca-Carrera E, Hampp C, Yanoff L. Cancer risk associated with lorcaserin — The FDA’s review of the CAMELLIA-TIMI 61 trial. N Engl J Med 2020;383:10 de septiembe. [Ref.ID 103713]
8.Enlace a cita original Cita con resumen
Hill K, Sucha E, Rhodes E, Carrier M, Garg AX, Harel Z, Hundemer GL, Clark EG, Knoll G, McArthur E, Sood MM. Risk of hospitalization with hemorrhage among older adults taking clarithromycin vs azithromycin and direct oral anticoagulants. JAMA Intern Med 2020;180:agosto. [Ref.ID 103655]
9. Cita con resumen
Blotière P-O, Miranda S, Weill A, Mikaeloff Y, Peyre H, Ramus F, Zureik M, Coste J, Dray-Spira R. Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy: a French nationwide population-based cohort study. BMJ Open 2020;10:e034829. [Ref.ID 103654]
10. Cita con resumen
Mahévas M, Tran V-T, Roumier M, Chabrol A, Paule R, Guillaud C, Fois E, Lepeule R, Szwebel T-A, Lescure F-X, Schlemmer F, Matignon M, Khellaf M, Crickx E, Terrier B, Morbieu C, Legendre P, Dang J, Schoindre Y, Pawlotsky J-M, Michel M, Perrodeau E, et al.. Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data. BMJ 2020;369:14 de mayo. [Ref.ID 103651]
11. Cita con resumen
12. Cita con resumen
Rydberg DM, Linder M, Malmström RE, Andersen M. Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication. Eur J Clin Pharmacol 2020;76:867-76. [Ref.ID 103644]
14. Cita con resumen
Wise J. Covid-19 and thrombosis: what do we know about the risks and treatment?. BMJ 2020;369:21 de mayo. [Ref.ID 103635]
15. Cita con resumen
Ing AJ, Cocks C, Green JP. COVID-19: in the footsteps of Ernest Shackleton. Thorax 2020:27 de mayo. [Ref.ID 103633]
16.Tiene citas relacionadas Cita con resumen
Mehra MR, Desai SS, Ruschitzka F, Patel AN. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet 2020:22 de mayo. [Ref.ID 103632]
17. Cita con resumen
Zhu H, Bateman BT, Gray KJ, Hernandez-Diaz S, Mogun H, Starub L, Huybrechts KF. Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study. BMJ 2020;369:20 de mayo. [Ref.ID 103628]
18. Cita con resumen
Pasternak B, Wintzell V, Melbye M, Eliasson B, Svensson A-M, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Svanström H, Ueda P. Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study. BMJ 2020;369:29 de abril. [Ref.ID 103626]
Seleccionar todas
 
 1 a 20 de 1784 siguiente >>